BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia

  April 23, 2025

   · 

  7 min read
• Press Releases

  Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

  April 23, 2025

   · 

  1 min read
• Press Releases

  OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

  April 23, 2025

   · 

  1 min read
• Press Releases

  Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

  April 23, 2025

   · 

  5 min read
• Press Releases

  Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors

  April 23, 2025

   · 

  7 min read
• Press Releases

  Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds

  April 23, 2025

   · 

  4 min read
• Press Releases

  Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)

  April 23, 2025

   · 

  9 min read
• Press Releases

  Hercules Pharmaceuticals Names Randy Erickson as Chief Growth Officer

  April 23, 2025

   · 

  1 min read
• Press Releases

  Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

  April 23, 2025

   · 

  5 min read
• Press Releases

  Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder

  April 23, 2025

   · 

  4 min read